Figure 6From: Value of diffusion weighted MR imaging as an early surrogate parameter for evaluation of tumor response to high-dose-rate brachytherapy of colorectal liver metastasesBoxplot depicting changes of mean ADC of non-treated and treated tumors at early and follow-up MRI compared to baseline MRI. Boxplot illustrates changes of mean ADC of non-treated and treated colorectal liver metastases 2 days (early MRI) as well as 3 months (follow-up MRI) following HDR-BT as compared to baseline MRI (*: p < 0.001).Back to article page